OKYO Pharma announces issuance of U.S. Patent No. 11,197,906 covering OKYO Pharma’s drug candidate OK-101 for use to treat dry eye disease
LONDON and BOSTON, Dec. 14, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; OTCQB:…
Month: December 2021
InnoSkel Appoints Dr Sophie Amsellem-Bosq as Chief Technical Officer
InnoSkel Appoints Dr Sophie Amsellem-Bosq as Chief Technical Officer Nice, France, 14 December 2021 –…
ERYTECH Announces $7.85 Million Registered Direct Offering
ERYTECH Announces $7.85 Million Registered Direct Offering Lyon (France) and Cambridge, MA (U.S.), December 14,…
Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol
Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol Companies will collaborate…
HUTCHMED Highlights HMPL-523 Clinical Data Presented at the 2021 ASH Annual Meeting
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Dec. 14, 2021 (GLOBE NEWSWIRE) —…
Update on Novartis Agreement
NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Agios Presents Mitapivat Long-term Extension Data Demonstrating Durability of Hemoglobin Response and Transfusion Burden Reduction in Adults with Pyruvate Kinase (PK) Deficiency at 63rd ASH Annual Meeting and Exposition
– Additional Data Presented at ASH Support the Potential of Mitapivat to Improve Ineffective Erythropoiesis…
Tessa Therapeutics Announces Positive Data from Phase 2 Trial of Autologous CD30-CAR-T Therapy (TT11) in Relapsed or Refractory Classical Hodgkin Lymphoma at 2021 ASH Annual Meeting
Oral poster highlights data from 14 heavily pre-treated patients enrolled in pilot stage of multicenter,…
Freeline Announces 2022 Corporate Priorities and Guidance
Promising execution in the clinic with programs in hemophilia B, Fabry disease and Gaucher disease;…
Sigilon Therapeutics Announces Strategic Reprioritization
– Company plans to prioritize MPS-1 and diabetes with continued focus on platform optimization –…
Fate Therapeutics Showcases Positive Interim Phase 1 Data from FT596 Off-the-shelf, iPSC-derived CAR NK Cell Program for Relapsed / Refractory B-cell Lymphoma at 2021 ASH Annual Meeting
5 of 6 Patients Achieve Objective Response, including 4 Patients with Complete Response, with Single…
HM43239 Demonstrates Durable Clinical Benefit in Acute Myeloid Leukemia
HM43239 Data Featured in Oral Presentation at the American Society of Hematology Annual Meeting Aptose Presents…
Vaxil Announces Resignation of Director
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 13, 2021…
Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. Yang
FREMONT, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company,…
ORIC Pharmaceuticals Presents Data Supporting the Therapeutic Potential of ORIC-533 in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting
CD73 inhibition overcomes immunosuppression and demonstrates activity in assays derived from relapsed or refractory multiple…
Centessa Pharmaceuticals Announces Addition to NASDAQ Biotechnology Index
BOSTON and LONDON, Dec. 13, 2021 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (“Company”) (Nasdaq: CNTA), a…
Corrected: Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 63rd American Society of Hematology Annual Meeting and Exposition
Lexington, Mass. – December 13, 2021 – Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS) is re-issuing…
ProjectManager Announces Redesigned Mobile App to Improve Project & Work Management For Hybrid Teams
AUSTIN, Texas, Dec. 13, 2021 (GLOBE NEWSWIRE) — ProjectManager, a leading project and work management…
TapeReal Announces App Update and NON-FUNGIBLE MOMENTS™
TORONTO, Dec. 13, 2021 (GLOBE NEWSWIRE) — TapeReal has launched a new version of their…
Osterman Research Surveys Show IT & Security Decision-Makers Plan Investments in Multi-Factor Authentication & Zero Trust Solutions to Counter Rising Cyberthreats
WALL, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative…